
PrEP to be listed on PBS
Today, it has been announced that the Pharmaceutical Benefits Advisory Committee (PBAC) recommend that the HIV prevention drug, PrEP, be listed on the Pharmaceutical Benefits Scheme PBS). TIM welcomes this announcement from PBAC. PrEP is a necessary and urgent...